Evidence map›Paper›PMID 24711543›Full record

ArticleEMBO reports2014

BIG3 inhibits insulin granule biogenesis and insulin secretion.

Hongyu Li, Shunhui Wei, Kenneth Cheng, Natalia V Gounko, Russell E Ericksen, Aimin Xu, Wanjin Hong, Weiping Han

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. The Journal of cell biology · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Hongyu LiInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Shunhui WeiSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Kenneth ChengState Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China Department of Medicine, University of Hong Kong, Hong Kong, China.
Natalia V GounkoInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore Joint IMB-IMCB Electron Microscopy Suite, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Russell E EricksenSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
Aimin XuState Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China Department of Medicine, University of Hong Kong, Hong Kong, China Pharmacology and Pharmacy, University of Hong Kong, Hong Kong, China.
Wanjin HongInstitute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore weiping_han@sbic.a-star.edu.sg mcbhwj@imcb.a-star.edu.sg.
Weiping HanSingapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore weiping_han@sbic.a-star.edu.sg mcbhwj@imcb.a-star.edu.sg.
Singapore Bioimaging Consortium · SGAgency for Science, Technology and Research · SGUniversity of Hong Kong · HKInstitute of Molecular and Cell Biology · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While molecular regulation of insulin granule exocytosis is relatively well understood, insulin granule biogenesis and maturation and its influence on glucose homeostasis are relatively unclear. Here, we identify a novel protein highly expressed in insulin-secreting cells and name it BIG3 due to its similarity to BIG/GBF of the Arf-GTP exchange factor (GEF) family. BIG3 is predominantly localized to insulin- and clathrin-positive trans-Golgi network (TGN) compartments. BIG3-deficient insulin-secreting cells display increased insulin content and granule number and elevated insulin secretion upon stimulation. Moreover, BIG3 deficiency results in faster processing of proinsulin to insulin and chromogranin A to β-granin in β-cells. BIG3-knockout mice exhibit postprandial hyperinsulinemia, hyperglycemia, impaired glucose tolerance, and insulin resistance. Collectively, these results demonstrate that BIG3 negatively modulates insulin granule biogenesis and insulin secretion and participates in the regulation of systemic glucose homeostasis.

Indexed as

AnimalsCalorimetry, IndirectGlucoseHomeostasisHyperglycemiaInsulinInsulin ResistanceInsulin-Secreting CellsInsulin SecretionIntracellular Signaling Peptides and ProteinsMiceMice, KnockoutProteinsSecretory Vesiclestrans-Golgi NetworkGlucoseInsulinIntracellular Signaling Peptides and ProteinsProteinsWdr5 protein, mouseinsulin granule biogenesisinsulin resistanceinsulin secretionmetabolismproinsulin processing

Identifiers

PMID24711543
PMCPMC4197882
OpenAlexW2137844318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.